Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-13
2008-05-13
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S370000, C548S190000, C544S133000
Reexamination Certificate
active
07371751
ABSTRACT:
The present invention relates to compounds of formula (I)wherein R1, R2, R3and R4are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, including obesity.
REFERENCES:
patent: 3940418 (1976-02-01), Hamilton
patent: 5462960 (1995-10-01), Barth et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 576357 (1993-06-01), None
patent: 656 354 (1994-11-01), None
patent: 656 354 (1994-11-01), None
patent: 658 546 (1994-12-01), None
patent: 658 546 (1994-12-01), None
patent: WO 96/02248 (1996-02-01), None
patent: WO 97/19063 (1997-05-01), None
patent: WO 00/15609 (2000-03-01), None
patent: WO 00/46209 (2000-08-01), None
patent: WO 01/32663 (2001-05-01), None
patent: WO 01/64632 (2001-09-01), None
patent: WO 01/64633 (2001-09-01), None
patent: WO 01/64634 (2001-09-01), None
patent: WO 01/70700 (2001-09-01), None
patent: WO 02/28346 (2002-04-01), None
patent: WO 03/072577 (2003-09-01), None
patent: WO2004/014884 (2004-02-01), None
patent: WO 2004/014884 (2004-02-01), None
F. Barth, et. al., “Cannabinoid antagonists: From research tools to potential new drugs.” Abstracts of Papers, 222ndASC National Meeting, Chicago, IL Aug. 26-30, 2001.
F.M. Casiano, et. al., NIDA Res. Monogr. 105 (1991) 295-6.
G. Colombo, et. al., Life Sci. 63 (8) (1998) L-113-PL117.
W.A. Devane, et. al., Science 258 (1992) 1946-9.
V. Di Marzo, et. al., Nature 410 (6830) 822-825.
V. Di Marzo, et. al, Trends in Neuroscience 21 (12) (1998) 521-8.
C. Felder, et. al., J. Pharmacol. Exp. Ther. 284 (1) (1998) 291-7.
C. Felder, et. al., Proc. Natl. Acad. Sci. USA 90 (16) (1993) 7656-60.
Y. Gaoni, et. al., J. Am. Chem. Soc., 86 (1964) 1646.
K. Hosohata, et. al., Life Sci. 61 (1997) 115-118.
M. Kanyonyo, et. al., Bioorg. Med. Chem. Lett. 9 (15) (1999) 2233-2236.
R. Mechoulam (Ed.) in “Cannabinoids as therapeutic Agents”, (1986) p. 1-20, CRC Press.
S. Munro, et. al., Nature 365 (1993) 61-61.
F. Ooms, et. al., J. Med. Chem 45 (9) (2002) 1748-1756.
M. Pacheco, et. al., J. Pharmacol. Exp. Ther. 257 (1) (1991) 170-183.
R.G. Pertwee, Curr. Med. Chem., 6 (8) (1999) 635-664.
R.G. Pertwee, Life Sci. 56 (23-24) (1995) 1949-55.
R.G. Pertwee, Pharmaceut. Sci. 3 (11) (1997) 539-545.
C. Porter, et. al., Pharmacol. Ther., 90 (1) (2001) 45-60.
D. Shire, J. Biol. Chem. 270 (8) (1995) 3726-31.
C.M. Williams, et. al., Psychopharmacology 143 (3) (1999) 315-317.
E.M. Williamson, et. al., Drugs 60 (6) (2000) 1303-1314.
Shipps, Jr., et. al., Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 15, No. 1, Oct. 28, 2004, p. 115-119.
Pertwee, Pharmacol. Ther. vol. 74, No. 2, p. 129-180 (1997).
Nettekoven Matthias Heinrich
Roever Stephan
Hoffmann-La Roche Inc.
Johnston George W.
Saeed Kamal A.
Tramaloni Dennis P.
LandOfFree
Thiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2778027